AI + live data · analyst records & stock signals

Leaderboard Membership Builder

Connect your AI client via MCP

Endpoint (paste into an MCP client — anonymous, free, no key)

https://mcp.koalcheck.com/mcp

Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

Capabilities User guide

← @crypto_biotech

$GLSI

BULLISH2026-07-22

Price around the call

↑ 2026-07-22

By horizonMaturing · ~19 trading days to go

1d

✗ -1.7%

5d

…

21d

…

Original post

BioPharm_the_Magnificent · 2026-07-22

$GLSI Top 3 takeaways from today’s GLSI press release: 1. Royal Marsden is the lead🔥  They’re partnering with The Royal Marsden (one of the world’s top cancer centers). Their principal investigator will be the UK national PI and will also join the trial’s Steering Committee. This is a meaningful 😎credibility upgrade. 2. UK regulatory approval is official. 👊🏻  FLAMINGO-01 can now open in the United Kingdom. They’re targeting 5–10 sites at major academic centers (London, Cambridge, Oxford, Edinburgh, Manchester, etc.). 3. Enrollment expansion into a large new market.  The UK has ~59,400 new breast cancer cases per year and a population of 70 million. MONEYLINE: The company says patient interest in the UK was the original driver for this expansion.👍